# Bail Capital

> Bail Capital is a VC fund backing Health Care, Medical and Pharmaceutical. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 3
- Last investment: Jan 2024
- Lead investor: 0%
- Last updated: Aug 2026

Bail Capital is an investment Firm.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 3 | 100% |
| Medical | 2 | 67% |
| Pharmaceutical | 2 | 67% |
| Email | 1 | 33% |
| Legal | 1 | 33% |

9 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 33% |
| Series B | 1 | 33% |
| Funding Round | 1 | 33% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Canada | 1 | 33% |
| United States | 1 | 33% |
| United Kingdom | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Lykos Therapeutics | Lykos Therapeutics' goal is to revolutionize the way mental health is addressed. By creating innovative medicines and therapeutic techniques to treat mental health disorders, we hope to upend the status quo. With over thirty years of expertise investigating therapies aided by psychedelics, we continue to be committed to adhering to rigorousscience so that we can create and market innovative treatment alternatives. | $100M | Series A | Jan 05, 2024 |  |
| Beckley Psytech | Beckley Psytech operates as a psychedelic medicine company. The company is involved in exploring the therapeutic potential of psychedelic substances, such as psilocybin and other compounds, for mental health treatment. The company envisions the integration of clinically validated psychedelic medicines into contemporary medical practices to assistindividuals coping with depression and other significantly debilitating neuropsychiatric conditions characterized by a substantial unmet need. |  |  | Dec 23, 2020 |  |
| Cybin | Cybin is a biotechnology company focused on progressing psychedelic therapeutics by utilizing proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches and treatment regimens for psychiatric disorders. Cybin's mission is to revolutionize mental healthcare. | $33.1M | Series B | Jul 01, 2020 |  |

3 of 3 investments shown.

## Co-investors
- Noetic Fund — VC Fund, 2 deals together
- [Bicycle Day Ventures](https://shizune.co/investors/profile/bicycle-day-ventures) — VC Fund, 1 deal together
- EIR Pharmaceuticals — VC Fund, 1 deal together
- Helena — VC Fund, 1 deal together
- [Helena](https://shizune.co/investors/profile/helena-special-investments) — VC Fund, 1 deal together
- [Janus Henderson Investors](https://shizune.co/investors/profile/janus-henderson-investors) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Bail Capital invest in?

Bail Capital invests primarily in Health Care, Medical and Pharmaceutical startups, most often at Series A and Series B stage. Most of the 3 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Bail Capital last invest?

The most recent investment recorded for Bail Capital closed in Jan 2024. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co